These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Theranostics could be big business in precision oncology. Arnold C Nat Med; 2022 Apr; 28(4):606-608. PubMed ID: 35440719 [No Abstract] [Full Text] [Related]
7. Driving Precision Oncology to Clinical Practice: The Road Ahead from Biomarker Validation to Clinical Decision Systems. Yılmaz BK; Arğa KY OMICS; 2022 Jun; 26(6):358-359. PubMed ID: 35549456 [No Abstract] [Full Text] [Related]
8. Entering the era of precision medicine in pediatric oncology. Hadjadj D; Deshmukh S; Jabado N Nat Med; 2020 Nov; 26(11):1684-1685. PubMed ID: 33077957 [No Abstract] [Full Text] [Related]
9. Toward Project Optimus for Oncology Precision Medicine: Multi-Dimensional Dose Optimization Enabled by Quantitative Clinical Pharmacology. Venkatakrishnan K; van der Graaf PH Clin Pharmacol Ther; 2022 Nov; 112(5):927-932. PubMed ID: 36264968 [No Abstract] [Full Text] [Related]
10. Next-Generation Sequencing in Oncology in the Era of Precision Medicine. Blumenthal GM; Mansfield E; Pazdur R JAMA Oncol; 2016 Jan; 2(1):13-4. PubMed ID: 26540172 [No Abstract] [Full Text] [Related]
11. Giving Up on Precision Oncology? Not So Fast! Warner JL Clin Transl Sci; 2017 May; 10(3):128-129. PubMed ID: 28146309 [No Abstract] [Full Text] [Related]
12. Delivering on the promise of precision cancer medicine. Berger MF; Van Allen EM Genome Med; 2016 Oct; 8(1):110. PubMed ID: 27782852 [No Abstract] [Full Text] [Related]
13. The value of companion diagnostics in oncology drug development. Conn CW; Jin J Expert Rev Mol Diagn; 2022 Jun; 22(6):591-593. PubMed ID: 35815729 [No Abstract] [Full Text] [Related]
14. Personalized medicine in oncology: next generation. Chiang A; Million RP Nat Rev Drug Discov; 2011 Dec; 10(12):895-6. PubMed ID: 22129983 [No Abstract] [Full Text] [Related]
16. Precision medicine in pediatric oncology. Forrest SJ; Geoerger B; Janeway KA Curr Opin Pediatr; 2018 Feb; 30(1):17-24. PubMed ID: 29189430 [TBL] [Abstract][Full Text] [Related]
17. Precision oncology: Directing genomics and pharmacogenomics toward reducing cancer inequities. Saulsberry L; Olopade OI Cancer Cell; 2021 Jun; 39(6):730-733. PubMed ID: 34019805 [No Abstract] [Full Text] [Related]
18. Precision medicine and oncology: an overview of the opportunities presented by next-generation sequencing and big data and the challenges posed to conventional drug development and regulatory approval pathways. Doherty M; Metcalfe T; Guardino E; Peters E; Ramage L Ann Oncol; 2016 Aug; 27(8):1644-6. PubMed ID: 27117532 [No Abstract] [Full Text] [Related]
19. [Precision medicine in oncology: Challenges, stakes and new paradigms]. Cox S; Rousseau-Tsangaris M; Abou-Zeid N; Dalle S; Leurent P; Cutivet A; Le HH; Kotb S; Bogaert B; Gardette R; Baran Y; Holder JM; Lerner L; Blay JY; Cambrosio A; Tredan O; Denèfle P Bull Cancer; 2019 Feb; 106(2):97-104. PubMed ID: 30713005 [No Abstract] [Full Text] [Related]
20. Mind the Gap: Precision Oncology and Its Potential to Widen Disparities. Huey RW; Hawk E; Offodile AC J Oncol Pract; 2019 Jun; 15(6):301-304. PubMed ID: 31112478 [No Abstract] [Full Text] [Related] [Next] [New Search]